Real-time enrollment status for this oropharyngeal carcinoma (opc) clinical trial
Current Status
Recruiting
Checked: October 8, 2026 at 9:35 PM UTC
| NCT Number | NCT07768189 |
| Recruiting Status | Recruiting |
| Condition | Oropharyngeal Carcinoma (OPC) |
| Phase | PHASE3 |
| Target Enrollment | 260 participants |
| Active Locations | 38 sites in the US |
| Sponsor | Corbus Pharmaceuticals Inc. |
| Last Updated on CT.gov | October 8, 2026 (21 hours ago) |
As of October 8, 2026: Clinical trial NCT07768189 is currently recruiting participants. This phase3 study for oropharyngeal carcinoma (opc) is actively seeking new participants at 38 locations across the United States. The study is sponsored by Corbus Pharmaceuticals Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07768189 is actively recruiting participants as of October 8, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 38 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07768189 was last updated 21 hours ago (October 8, 2026). HelloStudys verifies this status automatically.